What is Design Therapeutics, Inc.'s PP&E (net)?

Design Therapeutics, Inc. (DSGN) reported PP&E (net) of $824K in Q1 2026.

How has Design Therapeutics, Inc.'s PP&E (net) changed year-over-year?

Design Therapeutics, Inc.'s PP&E (net) decreased by 40.2% year-over-year, from $1.38M to $824K.

What is the long-term trend for Design Therapeutics, Inc.'s PP&E (net)?

Over 5 years (2020 to 2025), Design Therapeutics, Inc.'s PP&E (net) has grown at a 69.1% compound annual growth rate (CAGR), from $71K to $981K.

What does PP&E (net) mean?

Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

Design Therapeutics, Inc. DSGN PP&E (Net)

PP&E (Net) at other companies

ALN

Alnylam PharmaceuticalsALNY

$518.26M+3.9%

Intellia TherapeuticsNTLA

$15.52M-38.2%

CRISPR TherapeuticsCRSP

$112.18M-13.3%

Dyne Therapeutics, Inc.DYN

$23.68M+312%

Vor BiopharmaVOR

$565K-90.6%

Taysha Gene Therapies, Inc.TSHA

$6.45M-10.9%

Other financials

Income statement

See full

Revenue-—

Operating income-$19.7M+3.5%

Net income-$17.6M+0.4%

EPS (diluted)-$0.29+6.5%

Balance sheet

See full

Cash & equivalents$12.8M-6.6%

Total debt$2.7M+27.7%

Total equity$218.1M-4.3%

Total assets$230.4M-3.0%

Cash flow

See full

Operating cash flow-$16.4M+2.1%

CapEx--100%

Free cash flow-$16.4M+2.6%

Valuation

See full

Market cap$860.66M+305%

Enterprise value$850.62M+324%

Profitability

See full

Operating margin-3,685.8%—

Net margin-3,663.7%—

Returns & leverage

See full

Return on equity-31.3%+19.5pp

Debt / equity0×0.0×

Current ratio22.3×-6.1×

Where this comes from

Reported directly by Design Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Design Therapeutics, Inc.’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Design Therapeutics, Inc.'s pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Design Therapeutics, Inc.'s PP&E (net)?: Design Therapeutics, Inc. (DSGN) reported PP&E (net) of $824K in Q1 2026.
How has Design Therapeutics, Inc.'s PP&E (net) changed year-over-year?: Design Therapeutics, Inc.'s PP&E (net) decreased by 40.2% year-over-year, from $1.38M to $824K.
What is the long-term trend for Design Therapeutics, Inc.'s PP&E (net)?: Over 5 years (2020 to 2025), Design Therapeutics, Inc.'s PP&E (net) has grown at a 69.1% compound annual growth rate (CAGR), from $71K to $981K.
What does PP&E (net) mean?: Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.